CUL-4A has been implicated in several cancers and the pathogenesis of certain viruses including HIV.
| Institute |
|---|
| University of Illinois Chicago |
| SKU: | 156385 |
|---|---|
| Product description: | CUL-4A regulates numerous key processes such as DNA repair, chromatin remodeling, spermatogenesis, haematopoiesis and the mitotic cell cycle. Moreover, CUL-4A is a core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination of target proteins. As a result, CUL-4A has been implicated in several cancers and the pathogenesis of certain viruses including HIV. |
| Alternate name: | CUL-4A |
| Conjugation: | Unconjugated |
| Immunogen: | Synthetic peptide (ERDKDNPNQYHYVA) (746-759, C-terminus peptide), corresponding to human CUL-4A was conjugated to maleimide-activated keyhole limpet hemocyanin |
| Cat. #: | 156385 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Biochemistry;Cancer;Cell biology;Genetics |
| Application: | WB ; IP ; ChIP ; ELISA ; IHC |
| Target: | Cullin 4A |
| Reactivity: | Human ; Mouse |
| Host: | Rabbit |
| Class: | Polyclonal |
| Target background: | CUL-4A regulates numerous key processes such as DNA repair, chromatin remodeling, spermatogenesis, haematopoiesis and the mitotic cell cycle. Moreover, CUL-4A is a core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination of target proteins. As a result, CUL-4A has been implicated in several cancers and the pathogenesis of certain viruses including HIV. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Sharma et al. 2014. Open Biol. 4:130217. PMID: 24522884. Shiyanov et al. 1999. J Biol Chem. 274(50):35309-12. PMID: 10585395. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.